Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828554 · ClinicalTrials.gov registry record · NA
Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight
A NA study, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT01828554 is a NA study that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 8 participants.
The verdict
NCT01828554, a NA study, has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this research study is to find what happens to capecitabine in the body when dosed using actual versus ideal body weight in subjects with advanced tumors and elevated body mass index.
Interventions
- DRUG Xeloda
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-06 |
| Est. Completion | 2018-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01828554
The ClinicalTrials.gov registry entry for NCT01828554 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Xeloda is the first listed.
NCT01828554 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01828554 about?
NCT01828554 is a clinical study titled "Capecitabine Pharmacokinetics(PK)-Actual Versus Ideal Body Weight". The purpose of this research study is to find what happens to capecitabine in the body when dosed using actual versus ideal body weight in subjects with advanced tumors and elevated body mass index.
What is the current status of trial NCT01828554?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2013-06. Estimated completion is 2018-04.
What interventions are being tested in trial NCT01828554?
The interventions under investigation include: Xeloda (DRUG).
Who is sponsoring clinical trial NCT01828554?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.